|
US4179337A
(en)
|
1973-07-20 |
1979-12-18 |
Davis Frank F |
Non-immunogenic polypeptides
|
|
US4292250A
(en)
|
1980-11-17 |
1981-09-29 |
Wisconsin Alumni Research Foundation |
Vitamin D derivatives
|
|
US4675189A
(en)
|
1980-11-18 |
1987-06-23 |
Syntex (U.S.A.) Inc. |
Microencapsulation of water soluble active polypeptides
|
|
US4410515A
(en)
|
1981-04-01 |
1983-10-18 |
Massachusetts General Hospital |
Vitamin D glycosides and a method of use
|
|
US4456553A
(en)
|
1982-05-07 |
1984-06-26 |
Teijin Limited |
Vitamin D3 derivatives, process for preparation thereof, and antigens comprising said derivatives to be used for preparation of antibodies for immunochemical assay and antibodies prepared therefrom
|
|
US4816567A
(en)
|
1983-04-08 |
1989-03-28 |
Genentech, Inc. |
Recombinant immunoglobin preparations
|
|
US5550111A
(en)
|
1984-07-11 |
1996-08-27 |
Temple University-Of The Commonwealth System Of Higher Education |
Dual action 2',5'-oligoadenylate antiviral derivatives and uses thereof
|
|
NZ217821A
(en)
|
1985-10-10 |
1989-07-27 |
Biotech Australia Pty Ltd |
Oral delivery system; complex of active agent and vitamin b12 or analogue thereof
|
|
JPH02274A
(ja)
|
1987-10-14 |
1990-01-05 |
Toyo Jozo Co Ltd |
新規な２５−ヒドロキシビタミンｄ↓３誘導体およびその製造法およびそれを用いた定量法
|
|
US5232836A
(en)
*
|
1988-05-04 |
1993-08-03 |
Ire-Medgenix S.A. |
Vitamin D derivatives: therapeutic applications and applications to assays of metabolites of vitamin D
|
|
FR2631025B1
(fr)
*
|
1988-05-04 |
1991-04-12 |
Ire Medgenix Sa |
Nouveaux derives de la vitamine d3 et application aux dosages des metabolites de la vitamine d3
|
|
US5214170A
(en)
|
1988-10-05 |
1993-05-25 |
Toyo Jozo Kabushiki Kaisha |
Radioisotope iodine-labeled 1α (or 24R), 25-dihydroxy vitamin D3
|
|
GB8823869D0
(en)
|
1988-10-12 |
1988-11-16 |
Medical Res Council |
Production of antibodies
|
|
US5116964A
(en)
|
1989-02-23 |
1992-05-26 |
Genentech, Inc. |
Hybrid immunoglobulins
|
|
US5688488A
(en)
|
1989-04-03 |
1997-11-18 |
Purdue Research Foundation |
Composition and method for tumor imaging
|
|
US5108921A
(en)
|
1989-04-03 |
1992-04-28 |
Purdue Research Foundation |
Method for enhanced transmembrane transport of exogenous molecules
|
|
US5122614A
(en)
|
1989-04-19 |
1992-06-16 |
Enzon, Inc. |
Active carbonates of polyalkylene oxides for modification of polypeptides
|
|
SE509359C2
(sv)
|
1989-08-01 |
1999-01-18 |
Cemu Bioteknik Ab |
Användning av stabiliserade protein- eller peptidkonjugat för framställning av ett läkemedel
|
|
US5605690A
(en)
|
1989-09-05 |
1997-02-25 |
Immunex Corporation |
Methods of lowering active TNF-α levels in mammals using tumor necrosis factor receptor
|
|
US7217689B1
(en)
|
1989-10-13 |
2007-05-15 |
Amgen Inc. |
Glycosylation analogs of erythropoietin
|
|
US6395492B1
(en)
|
1990-01-11 |
2002-05-28 |
Isis Pharmaceuticals, Inc. |
Derivatized oligonucleotides having improved uptake and other properties
|
|
EP1690935A3
(en)
|
1990-01-12 |
2008-07-30 |
Abgenix, Inc. |
Generation of xenogeneic antibodies
|
|
ES2246502T3
(es)
|
1990-08-29 |
2006-02-16 |
Genpharm International, Inc. |
Animales no humanos transgenicos capaces de producir anticuerpos heterologos.
|
|
US5545806A
(en)
|
1990-08-29 |
1996-08-13 |
Genpharm International, Inc. |
Ransgenic non-human animals for producing heterologous antibodies
|
|
US5633425A
(en)
|
1990-08-29 |
1997-05-27 |
Genpharm International, Inc. |
Transgenic non-human animals capable of producing heterologous antibodies
|
|
US5661016A
(en)
|
1990-08-29 |
1997-08-26 |
Genpharm International Inc. |
Transgenic non-human animals capable of producing heterologous antibodies of various isotypes
|
|
US5625126A
(en)
|
1990-08-29 |
1997-04-29 |
Genpharm International, Inc. |
Transgenic non-human animals for producing heterologous antibodies
|
|
US5612034A
(en)
|
1990-10-03 |
1997-03-18 |
Redcell, Inc. |
Super-globuling for in vivo extended lifetimes
|
|
WO1992014493A1
(en)
|
1991-02-20 |
1992-09-03 |
Christopher Capelli |
Non-protein intracellular receptor binding conjugates and a method of use thereof
|
|
AU1674292A
(en)
|
1991-03-15 |
1992-10-21 |
Synergen, Inc. |
Pegylation of polypeptides
|
|
US7192584B2
(en)
|
1991-03-18 |
2007-03-20 |
Centocor, Inc. |
Methods of treating psoriasis with anti-TNF antibodies
|
|
US5919452A
(en)
|
1991-03-18 |
1999-07-06 |
New York University |
Methods of treating TNFα-mediated disease using chimeric anti-TNF antibodies
|
|
JP2823959B2
(ja)
|
1991-10-24 |
1998-11-11 |
アイシス・ファーマシューティカルス・インコーポレーテッド |
改良された取り込みおよびその他の性質を持つ誘導化オリゴヌクレオチド
|
|
WO1993012145A1
(en)
|
1991-12-19 |
1993-06-24 |
Baylor College Of Medicine |
Pva or peg conjugates of peptides for epitope-specific immunosuppression
|
|
FR2686899B1
(fr)
|
1992-01-31 |
1995-09-01 |
Rhone Poulenc Rorer Sa |
Nouveaux polypeptides biologiquement actifs, leur preparation et compositions pharmaceutiques les contenant.
|
|
US5447851B1
(en)
|
1992-04-02 |
1999-07-06 |
Univ Texas System Board Of |
Dna encoding a chimeric polypeptide comprising the extracellular domain of tnf receptor fused to igg vectors and host cells
|
|
US5470949A
(en)
|
1992-12-15 |
1995-11-28 |
The Arizona Board Of Regents On Behalf Of The University Of Arizona |
Method for making amino acid glycosides and glycopeptides
|
|
US5548064A
(en)
|
1993-05-24 |
1996-08-20 |
Biotech Australia Pty Limited |
Vitamin B12 conjugates with EPO, analogues thereof and pharmaceutical compositions
|
|
US6342225B1
(en)
|
1993-08-13 |
2002-01-29 |
Deutshces Wollforschungsinstitut |
Pharmaceutical active conjugates
|
|
CA2184002A1
(en)
|
1994-02-23 |
1995-08-31 |
Jeffrey M. Blaney |
Method and compositions for increasing the serum half-life of pharmacologically active agents
|
|
US6919441B2
(en)
|
1994-03-14 |
2005-07-19 |
Aventis Pharma Deutschland Gmbh |
Polyamide-oligonucleotide derivatives, their preparation and use
|
|
US5629384A
(en)
|
1994-05-17 |
1997-05-13 |
Consiglio Nazionale Delle Ricerche |
Polymers of N-acryloylmorpholine activated at one end and conjugates with bioactive materials and surfaces
|
|
US5574018A
(en)
|
1994-07-29 |
1996-11-12 |
Amgen Inc. |
Conjugates of vitamin B12 and proteins
|
|
EP0804456B1
(en)
|
1994-10-06 |
2002-08-21 |
Isis Pharmaceuticals, Inc. |
Peptide nucleic acid conjugates
|
|
US5932462A
(en)
|
1995-01-10 |
1999-08-03 |
Shearwater Polymers, Inc. |
Multiarmed, monofunctional, polymer for coupling to molecules and surfaces
|
|
US5739277A
(en)
|
1995-04-14 |
1998-04-14 |
Genentech Inc. |
Altered polypeptides with increased half-life
|
|
CA2219361C
(en)
|
1995-04-27 |
2012-02-28 |
Abgenix, Inc. |
Human antibodies derived from immunized xenomice
|
|
WO1996034096A1
(en)
|
1995-04-28 |
1996-10-31 |
Abgenix, Inc. |
Human antibodies derived from immunized xenomice
|
|
JP2000503641A
(ja)
|
1995-12-29 |
2000-03-28 |
エイ・アンド・ディ・アッセイ・インコーポレイテッド |
標識ビタミンｄ化合物およびその使用
|
|
GB9526733D0
(en)
|
1995-12-30 |
1996-02-28 |
Delta Biotechnology Ltd |
Fusion proteins
|
|
US5691328A
(en)
|
1996-02-02 |
1997-11-25 |
Clarion Pharmaceuticals Inc. |
Phosphoethanolamine conjugates of vitamin D compounds
|
|
AU2538797A
(en)
|
1996-03-22 |
1997-10-10 |
Trustees Of Boston University |
Photodynamic therapy using nuclear hormone receptors to target photosensitizers
|
|
EP1972194A1
(en)
|
1996-12-03 |
2008-09-24 |
Amgen Fremont Inc. |
Transgenic mammals having human ig loci including plural vh and vk regions and antibodies produced therefrom
|
|
US20030129194A1
(en)
|
1997-02-13 |
2003-07-10 |
Bone Care International, Inc. |
Targeted therapeutic delivery of vitamin D compounds
|
|
NZ336924A
(en)
|
1997-02-13 |
2001-06-29 |
Bone Care Int Inc |
Targeted therapeutic delivery of vitamin D compounds via a Vitamin D conjugate
|
|
US6093701A
(en)
|
1997-12-12 |
2000-07-25 |
Mirus, Inc. |
Method for covalent attachment of compounds to genes
|
|
US6372712B1
(en)
|
1998-05-22 |
2002-04-16 |
The Board Of Trustees Of The Leland Stanford Jr. University |
Synthetic bifunctional molecules containing a drug moiety and presenter protein ligand
|
|
US6537806B1
(en)
|
1998-06-02 |
2003-03-25 |
University Of Washington |
Compositions and methods for treating diabetes
|
|
AU763458B2
(en)
|
1998-06-25 |
2003-07-24 |
Biomedica Gmbh |
Functional vitamin D derivatives and a method for determining 25-hydroxy-vitamin D and 1alpha,25-dihydroxy-vitamin D
|
|
US6660843B1
(en)
|
1998-10-23 |
2003-12-09 |
Amgen Inc. |
Modified peptides as therapeutic agents
|
|
EP1151102B1
(en)
|
1999-02-12 |
2006-04-19 |
Amgen Inc. |
Glycosylated leptin compositions and related methods
|
|
US6713280B1
(en)
|
1999-04-07 |
2004-03-30 |
Thomas Jefferson University |
Enhancement of peptide cellular uptake
|
|
AUPQ014699A0
(en)
|
1999-05-04 |
1999-05-27 |
Access Pharmaceuticals Australia Pty Limited |
Amplification of folate-mediated targeting to tumor cells using nanoparticles
|
|
US6887470B1
(en)
|
1999-09-10 |
2005-05-03 |
Conjuchem, Inc. |
Protection of endogenous therapeutic peptides from peptidase activity through conjugation to blood components
|
|
AU765753B2
(en)
|
1999-05-17 |
2003-09-25 |
Conjuchem Biotechnologies Inc. |
Protection of endogenous therapeutic peptides from peptidase activity through conjugation to blood components
|
|
PT1180121E
(pt)
|
1999-05-17 |
2004-03-31 |
Conjuchem Inc |
Peptidos insulinotropicos de longa duracao
|
|
AUPQ071299A0
(en)
|
1999-06-02 |
1999-06-24 |
Access Pharmaceuticals Australia Pty Limited |
Vitamin directed dual targeting therapy
|
|
CA2380058C
(en)
|
1999-07-23 |
2011-08-09 |
Kenji Kangawa |
Novel peptides
|
|
US7608681B2
(en)
|
1999-12-24 |
2009-10-27 |
Genentech, Inc. |
Methods and compositions for prolonging elimination half-times of bioactive compounds
|
|
SI1724284T1
(sl)
|
2000-12-07 |
2009-12-31 |
Lilly Co Eli |
Glp-1 fuzijski proteini
|
|
CA2435563A1
(en)
|
2001-02-02 |
2002-08-15 |
Conjuchem Inc. |
Long lasting growth hormone releasing factor derivatives
|
|
DK1360202T3
(da)
|
2001-02-16 |
2008-09-22 |
Conjuchem Biotechnologies Inc |
Langvarigt glucagon-lignende peptid 2 (GLP-2) til behandling af gastrointestinale sygdomme og lidelser
|
|
US7211395B2
(en)
|
2001-03-09 |
2007-05-01 |
Dyax Corp. |
Serum albumin binding moieties
|
|
ES2242860T3
(es)
|
2001-05-31 |
2005-11-16 |
Conjuchem, Inc. |
Inhibidores peptidicos de fusion de larga vida contra infecciones por vih.
|
|
WO2003011213A2
(en)
|
2001-07-30 |
2003-02-13 |
Eli Lilly And Company |
Method for treating diabetes and obesity
|
|
WO2003013573A1
(en)
|
2001-08-10 |
2003-02-20 |
Epix Medical, Inc. |
Polypeptide conjugates with extended circulating half-lives
|
|
US7176278B2
(en)
|
2001-08-30 |
2007-02-13 |
Biorexis Technology, Inc. |
Modified transferrin fusion proteins
|
|
WO2003025139A2
(en)
|
2001-09-17 |
2003-03-27 |
Mayo Foundation For Medical Education And Research |
Cobalamin mediated delivery of nucleic acids, analogs and derivatives thereof
|
|
US6858227B1
(en)
|
2001-11-21 |
2005-02-22 |
Sonus Pharmaceuticals, Inc. |
Vitamin E conjugates
|
|
CA2841097A1
(en)
|
2001-12-21 |
2003-07-24 |
Human Genome Sciences, Inc. |
Albumin and g-csf fusion proteins
|
|
EP1483277A4
(en)
|
2002-02-15 |
2007-10-03 |
Merckle Gmbh |
CONJUGATES OF BIOLOGICALLY ACTIVE COMPOUNDS, PROCESS FOR THEIR PREPARATION AND USE, FORMULATION AND PHARMACEUTICAL APPLICATIONS THEREOF
|
|
US20040186063A1
(en)
|
2002-02-15 |
2004-09-23 |
Hans-Jurgen Gutke |
Conjugates of biologically active compounds, methods for their preparation and use, formulation and pharmaceutical applications thereof
|
|
US7591994B2
(en)
|
2002-12-13 |
2009-09-22 |
Immunomedics, Inc. |
Camptothecin-binding moiety conjugates
|
|
DE10209821A1
(de)
*
|
2002-03-06 |
2003-09-25 |
Biotechnologie Ges Mittelhesse |
Kopplung von Proteinen an ein modifiziertes Polysaccharid
|
|
RU2325202C2
(ru)
|
2002-07-19 |
2008-05-27 |
Цитос Байотекнолоджи Аг |
Конъюгаты грелин-носитель
|
|
JP2006515271A
(ja)
|
2002-07-23 |
2006-05-25 |
ソシエテ・ドゥ・コンセイユ・ドゥ・ルシェルシュ・エ・ダプリカーション・シャンティフィック・エス・ア・エス |
グレリン類似体
|
|
EP1530588A2
(en)
|
2002-07-31 |
2005-05-18 |
Conjuchem, Inc. |
Long lasting natriuretic peptide derivatives
|
|
EP1539811A4
(en)
|
2002-09-16 |
2006-05-24 |
Elusys Therapeutics Inc |
PREPARATION OF BISPEQIFIC MOLECULES WITH POLYETHYLENE GLYCOL LINKER
|
|
NZ540194A
(en)
|
2002-11-08 |
2008-07-31 |
Ablynx Nv |
Single domain antibodies directed against tumour necrosis factor-alpha and uses therefor
|
|
US20040191196A1
(en)
|
2002-12-16 |
2004-09-30 |
Dov Tamarkin |
Novel conjugate compounds and dermatological compositions thereof
|
|
US20040132104A1
(en)
|
2003-01-07 |
2004-07-08 |
Sackrison James L. |
Vitamin D assay
|
|
US7601332B2
(en)
|
2003-01-27 |
2009-10-13 |
Endocyte, Inc. |
Vitamin receptor binding drug delivery conjugates
|
|
CN101239190B
(zh)
*
|
2003-01-27 |
2013-09-25 |
恩多塞特公司 |
维生素受体结合递药缀合物
|
|
AU2004221824B2
(en)
|
2003-03-14 |
2009-08-27 |
Ratiopharm Gmbh |
Branched water-soluble polymers and their conjugates
|
|
SI1648933T1
(sl)
|
2003-07-25 |
2010-01-29 |
Conjuchem Biotechnologies Inc |
Dolgo delujoäś inzulinski derivat in metoda zanj
|
|
US20060193821A1
(en)
|
2004-03-05 |
2006-08-31 |
Diener John L |
Aptamers to the human IL-12 cytokine family and their use as autoimmune disease therapeutics
|
|
EP1729790A4
(en)
|
2004-03-29 |
2009-09-30 |
Robin Polt |
AMPHIPATHIC GLYCOPEPTIDES
|
|
WO2005105071A1
(en)
|
2004-04-30 |
2005-11-10 |
Ben Gurion University Of The Negev Research And Development Authority Ltd. |
A topical composition containing a vitamin d derivative
|
|
WO2005113571A2
(en)
|
2004-05-13 |
2005-12-01 |
The University Of North Carolina At Chapel Hill |
Methods for the delivery of oligomeric compounds
|
|
US7906137B2
(en)
*
|
2004-05-21 |
2011-03-15 |
Mediplex Corporation, Korea |
Delivery agents for enhancing mucosal absorption of therapeutic agents
|
|
US20060045880A1
(en)
|
2004-08-23 |
2006-03-02 |
Krieg Paul A |
Methods for modulating angiogenesis and apoptosis with apelin compositions
|
|
CA2595695A1
(en)
|
2005-01-25 |
2006-08-03 |
Cell Therapeutics, Inc. |
Biologically active protein conjugates comprising (nn[s/t]) peptide repeats and having increased plasma half-life
|
|
US7833979B2
(en)
|
2005-04-22 |
2010-11-16 |
Amgen Inc. |
Toxin peptide therapeutic agents
|
|
US20060246523A1
(en)
|
2005-04-28 |
2006-11-02 |
Christopher Bieniarz |
Antibody conjugates
|
|
AU2006249144B2
(en)
|
2005-05-18 |
2011-11-17 |
Ablynx Nv |
Improved NanobodiesTM against Tumor Necrosis Factor-alpha
|
|
CN101273134B
(zh)
|
2005-07-27 |
2012-01-04 |
王庆华 |
用于预防和治疗ⅰ型和ⅱ型糖尿病的组合物和方法
|
|
CA2624124A1
(en)
|
2005-09-29 |
2007-04-12 |
F. Hoffmann-La Roche Ag |
Antibodies against 25-hydroxyvitamin d
|
|
JP2009513627A
(ja)
|
2005-10-27 |
2009-04-02 |
ペプトロン カンパニー リミテッド |
生理活性物質−血液蛋白質複合体及びこれを利用する生理活性物質の安定化方法
|
|
WO2007097934A2
(en)
|
2006-02-17 |
2007-08-30 |
Elusys Therapeutics, Inc. |
Methods and compositions for using erythrocytes as carriers for delivery of drugs
|
|
CA2644712C
(en)
|
2006-03-06 |
2016-09-13 |
Amunix, Inc. |
Unstructured recombinant polymers and uses thereof
|
|
ES2424970T3
(es)
|
2006-03-10 |
2013-10-10 |
Ipsen Pharma |
Uso de un agonista de la grelina para mejorar los efectos catabólicos del tratamiento con glucocorticoides
|
|
GB0616111D0
(en)
|
2006-06-16 |
2006-09-20 |
Ardana Bioscience Ltd |
Agents, methods and uses
|
|
EP2081949B1
(en)
|
2006-09-22 |
2014-12-10 |
GE Healthcare Dharmacon, Inc. |
Tripartite oligonucleotide complexes and methods for gene silencing by rna interference
|
|
EP2114437A2
(en)
|
2006-10-16 |
2009-11-11 |
ConjuChem Biotechnologies Inc. |
Modified corticotropin releasing factor peptides and uses thereof
|
|
US20100104626A1
(en)
|
2007-02-16 |
2010-04-29 |
Endocyte, Inc. |
Methods and compositions for treating and diagnosing kidney disease
|
|
AU2008223431B2
(en)
|
2007-03-05 |
2013-06-13 |
Syracuse University |
A conjugate of insulin and vitamin B12 for oral delivery
|
|
CN104127878A
(zh)
|
2007-03-14 |
2014-11-05 |
恩多塞特公司 |
结合配体连接的微管溶素递药缀合物
|
|
WO2008118013A2
(en)
|
2007-03-23 |
2008-10-02 |
To-Bbb Holding B.V. |
Targeted intracellular delivery of antiviral agents
|
|
ES2538111T3
(es)
|
2007-05-31 |
2015-06-17 |
Alizé Pharma SAS |
Grelina no acilada como agente terapéutico en el tratamiento de trastornos metabólicos
|
|
BRPI0812970A2
(pt)
|
2007-06-25 |
2019-09-24 |
Endocyte Inc |
conjugados contendo espaçadores hidrofílicos
|
|
WO2009045457A2
(en)
|
2007-10-02 |
2009-04-09 |
Rxi Pharmaceuticals Corp. |
Tripartite rnai constructs
|
|
US8076476B2
(en)
|
2007-11-15 |
2011-12-13 |
Avi Biopharma, Inc. |
Synthesis of morpholino oligomers using doubly protected guanine morpholino subunits
|
|
TWI489994B
(zh)
|
2008-03-17 |
2015-07-01 |
Baxter Healthcare Sa |
供免疫球蛋白及玻尿酸酶之皮下投藥之用的組合及方法
|
|
EP2262539B1
(en)
|
2008-04-01 |
2015-07-15 |
Novo Nordisk A/S |
Insulin albumin conjugates
|
|
PT2277890E
(pt)
|
2008-05-23 |
2016-03-31 |
Daiichi Sankyo Co Ltd |
Péptido capaz de prolongar o semi-período de vida do péptido de interesse no plasma
|
|
SG193860A1
(en)
|
2008-06-04 |
2013-10-30 |
Amgen Inc |
Fgf21 mutants and uses thereof
|
|
TWI451876B
(zh)
|
2008-06-13 |
2014-09-11 |
Lilly Co Eli |
聚乙二醇化之離脯胰島素化合物
|
|
CN105727261A
(zh)
|
2008-06-27 |
2016-07-06 |
杜克大学 |
包含弹性蛋白样肽的治疗剂
|
|
EP2350118B1
(en)
|
2008-09-19 |
2016-03-30 |
Nektar Therapeutics |
Carbohydrate-based drug delivery polymers and conjugates thereof
|
|
EP2342340A1
(en)
|
2008-09-22 |
2011-07-13 |
Rxi Pharmaceuticals Corporation |
Rna interference in skin indications
|
|
EP2370473B1
(en)
|
2008-12-10 |
2016-05-11 |
The Scripps Research Institute |
Production of carrier-peptide conjugates using chemically reactive unnatural amino acids
|
|
WO2010113157A1
(en)
|
2009-04-01 |
2010-10-07 |
Yeda Research And Development Co. Ltd. |
Lipopeptide inhibitors of hiv-1
|
|
CN102439044B
(zh)
|
2009-04-22 |
2014-08-13 |
阿特根公司 |
通过体内持续释放维持的体内半衰期增加的融合蛋白质或融合肽以及使用所述融合蛋白质或融合肽增加体内半衰期的方法
|
|
BRPI1011404B1
(pt)
|
2009-05-05 |
2022-05-03 |
Amgen Inc |
Polipeptídeos mutantes fgf21, polipeptídeo de fusão, multímero, composição farmacêutica, ácido nucleico isolado, vetor e célula hospedeira
|
|
AU2010246038A1
(en)
|
2009-05-05 |
2011-12-01 |
Amgen Inc. |
FGF21 mutants and uses thereof
|
|
JP5679458B2
(ja)
|
2009-09-28 |
2015-03-04 |
興和株式会社 |
内臓脂肪重量の低下剤
|
|
US20110097733A1
(en)
|
2009-10-27 |
2011-04-28 |
Michel Anciaux |
Process for the production of a hybridoma and antibody obtained therefrom, able to recognize more than one vitamin d metabolite
|
|
EP2695617B1
(en)
|
2009-12-23 |
2019-01-09 |
Glycomyr Inc. |
Vitamin D glycosides and sulfates for treating intestinal diseases
|
|
PL2525834T3
(pl)
|
2010-01-22 |
2020-10-19 |
Novo Nordisk Health Care Ag |
Hormony wzrostu o przedłużonej skuteczności in-vivo
|
|
EP4450523A3
(en)
|
2010-04-02 |
2025-03-12 |
Amunix Pharmaceuticals, Inc. |
Binding fusion proteins, binding fusion protein-drug conjugates, xten-drug conjugates and methods of making and using same
|
|
US8691771B2
(en)
|
2010-05-21 |
2014-04-08 |
Merrimack Pharmaceuticals, Inc. |
Bi-specific fusion proteins for tissue repair
|
|
WO2012032068A2
(en)
|
2010-09-06 |
2012-03-15 |
Modpro Ab |
Compounds and methods
|
|
EP3842074A1
(en)
*
|
2010-09-29 |
2021-06-30 |
Philogen S.p.A. |
Protein-drug conjugates
|
|
US9023791B2
(en)
|
2010-11-19 |
2015-05-05 |
Novartis Ag |
Fibroblast growth factor 21 mutations
|
|
EP4286400A3
(en)
|
2011-05-18 |
2024-06-05 |
Eumederis Pharmaceuticals, Inc. |
Improved peptide pharmaceuticals
|
|
US8785603B2
(en)
|
2011-05-20 |
2014-07-22 |
Siemens Healthcare Diagnostics Inc. |
Antibodies to 25-hydroxyvitamin D2 and D3 and uses thereof
|
|
US10023861B2
(en)
|
2011-08-29 |
2018-07-17 |
Ionis Pharmaceuticals, Inc. |
Oligomer-conjugate complexes and their use
|
|
WO2013033452A2
(en)
|
2011-08-31 |
2013-03-07 |
Amgen Inc. |
Method of treating or ameliorating type 1 diabetes using fgf21
|
|
ES2687651T3
(es)
|
2011-09-12 |
2018-10-26 |
Amunix Operating Inc. |
Composiciones de péptido-2 similar a glucagón y métodos para producir y usar los mismos
|
|
US9458214B2
(en)
|
2011-09-26 |
2016-10-04 |
Novartis Ag |
Dual function fibroblast growth factor 21 proteins
|
|
EP2768856A4
(en)
|
2011-10-18 |
2015-05-27 |
Prolynx Llc |
PEG CONJUGATES OF EXENATIDE
|
|
JP6165168B2
(ja)
|
2011-12-22 |
2017-07-19 |
ファイザー・インク |
抗糖尿病化合物
|
|
WO2013131091A1
(en)
|
2012-03-02 |
2013-09-06 |
New York University |
Chimeric fgf21 proteins with enhanced binding affinity for beta-klotho for the treatment of type ii diabetes, obesity and related metabolic disorders
|
|
WO2013163162A1
(en)
|
2012-04-24 |
2013-10-31 |
Amylin Pharmaceuticals, Llc |
Site-specific enzymatic modification of exendins and analogs thereof
|
|
MX349035B
(es)
|
2012-05-17 |
2017-07-07 |
Extend Biosciences Inc |
Portadores para el suministro mejorado de farmaco.
|
|
US9464126B2
(en)
|
2012-06-07 |
2016-10-11 |
New York University |
Chimeric fibroblast growth factor 21 proteins and methods of use
|
|
JP2015529076A
(ja)
|
2012-09-11 |
2015-10-05 |
ウニセンス ダイアグノスティクス エーピーエス |
鎖置換交換反応を使用する非核酸分析物の検出
|
|
EP2922877B1
(en)
|
2012-11-20 |
2018-09-05 |
Eumederis Pharmaceuticals, Inc. |
Improved peptide pharmaceuticals
|
|
US9290557B2
(en)
|
2012-11-28 |
2016-03-22 |
Ngm Biopharmaceuticals, Inc. |
Compositions comprising variants and fusions of FGF19 polypeptides
|
|
US9244083B2
(en)
|
2012-11-30 |
2016-01-26 |
Siemens Healthcare Diagnostics Inc. |
Compositions and methods for detecting vitamin D
|
|
SG11201504600UA
(en)
|
2012-12-10 |
2015-07-30 |
Hutchinson Fred Cancer Res |
Methods for screening
|
|
EP3434774A1
(en)
|
2013-01-17 |
2019-01-30 |
ModernaTX, Inc. |
Signal-sensor polynucleotides for the alteration of cellular phenotypes
|
|
CN112118859A
(zh)
*
|
2018-05-16 |
2020-12-22 |
杰特有限公司 |
1型可溶性补体受体变体及其用途
|